Increasing Developments by Key Players Are Boosting the Growth of the Global Epinephrine Market
Epinephrine Market |
Epinephrine Market - Global Forecast to 2026,
by Product Type (Auto-injector, Prefilled Syringes, and Ampoules and Vials), by
Application (Anaphylaxis, Cardiac Arrest, Superficial Bleeding, Respiratory
Disorders, and Others), by Distribution Channel (Hospital Pharmacies, Retail
Pharmacies, and Online Pharmacies) and by Region (North America, Latin America,
Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and
Opportunity Analysis, 2018-2026.
Market Overview:
Epinephrine, also known as adrenaline, is a
hormone and medication that plays a critical role in the body's stress response
and emergency situations. It belongs to a class of compounds called
catecholamines and is produced naturally by the adrenal glands, which are
located on top of the kidneys. Epinephrine acts as a neurotransmitter and a
hormone, exerting various physiological effects throughout the body.
Competitive Landscape:
Major players operating in the global Epinephrine Market include
ALK-Abelló A/S, BIOPROJET, USWM, LLC., Amneal Pharmaceuticals LLC., Bausch
Health Companies Inc., Kaleo, Inc., Viatris Inc., and Teva Pharmaceutical
Industries Ltd.
Key Market Drivers:
Allergic diseases, such as asthma, food
allergies, and allergic rhinitis, have been on the rise globally. The growing
prevalence of allergies drives the demand for epinephrine, as it is the primary
treatment for severe allergic reactions and anaphylaxis. The expanding population
of individuals with allergies is expected to augment the growth of the global
epinephrine market.
Anaphylaxis is a severe and potentially
life-threatening allergic reaction that requires immediate medical
intervention, including the administration of epinephrine. Increased awareness
about anaphylaxis among healthcare professionals, patients, and the general
public has resulted in early recognition and management of the condition,
driving the demand for epinephrine.
Innovations in drug delivery devices, such as
auto-injectors, have made the administration of epinephrine easier and more
accessible. Auto-injectors are user-friendly and allow for prompt
self-administration of epinephrine during emergencies. The availability of
convenient and reliable drug delivery devices has increased the adoption of
epinephrine. This is estimated to enhance the growth of the global epinephrine
market. For instance, in November 2021, Kaleo, Inc. was acquired by Marathon
Asset Management, in order to commercialize, manufacture and develop Kaleo’s
medical products.
Governments and regulatory bodies worldwide
have issued guidelines and recommendations for the management of anaphylaxis
and the availability of epinephrine in various settings, including schools,
public spaces, and healthcare facilities. These guidelines promote the use of
epinephrine and contribute to market growth by increasing its accessibility and
availability.
Covid-19 Impact Analysis:
The COVID-19 pandemic has highlighted the
importance of respiratory health and the need to manage underlying conditions
effectively. This increased focus on healthcare and hygiene measures may have
led to improved management of allergies and anaphylaxis, including the
appropriate use of epinephrine. This drove the growth of the global Epinephrine
Market. For instance, in November 2020, Upjohn and Mylan N.V. created
an international pharmaceutical company called Viatris Inc., in order to create
therapies targeted to cardiovascular diseases, infectious diseases, the central
nervous system, and anesthesia.
Key Takeaways:
·
North
America is expected to dominate the growth of the global epinephrine market,
owing to the high prevalence of allergies, strong healthcare infrastructure,
and increasing awareness about anaphylaxis management. The presence of major
market players and ongoing research activities also contribute to the region's
market dominance. For instance, in May 2020, Adamis Pharmaceuticals Corporation
and USWM, LLC. partnered in order to grant commercial rights to USWM, LLC., for
distributing and commercializing SYMJEPI injection.
·
The
Asia Pacific is witnessing high growth in the global epinephrine market, owing
to the increasing awareness about allergies and anaphylaxis, growing healthcare
expenditure, and improving access to healthcare facilities. The region's large
population and rising disposable incomes also contribute to market expansion.
For instance, according to the National Institutes of Health (NIH), around 3%
of the Indian population is suffering from asthma.
Comments
Post a Comment